Karyopharm Therapeutics | KPTI - القيمة السوقية





القيمة السوقية تغيير تاريخ
AbbVie USD 444.6B 59.91B 2026-06
Abbott USD 158.05B 20.36B 2026-06
Amgen USD 195.44B 5.55B 2026-06
AstraZeneca USD 289.99B 11.26B 2026-06
BioCryst Pharmaceuticals USD 2.54B 880M 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Eli Lilly USD 1.13T 260.54B 2026-06
Enanta Pharmaceuticals USD 122M 98M 2024-12
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Incyte USD 22.65B 3.92B 2026-06
J&J USD 611.36B 32.21B 2026-06
Karyopharm Therapeutics USD 126M 9M 2026-03
MacroGenics USD 184M 82M 2026-03
Merck USD 317.37B 20.27B 2026-06
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Novartis USD 240.59B 67.17B 2026-06
Novartis USD 288.26B 25.18B 2026-03
Pfizer USD 138.44B 15.37B 2026-06
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Takeda JPY 8.2T 809.7B 2026-06
Tectonic Therapeutic USD 580M 190M 2026-03
TG Therapeutics USD 8.41B 3.1B 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
Xencor USD 1.19B 301M 2026-06